Medistim ASASTU:MD1 -0.25%92 Interest Coverage is 142.03 as of Mar. 2026, which is 21% below its 10-year median of 178.82. GuruFocus rates STU:MD1 with a GF Score™ of 92/100 and a GF Value™ of €22.51. The stock has 1 warning sign investors should review. Among 466 Medical Devices & Instruments companies, Medistim ASA ranks better than 59.44% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Medistim ASA's
Operating Income
for the
three
months ended in Mar. 2026 was €5.11 Mil. Medistim ASA's Interest Expense for the
three
months ended in Mar. 2026 was €-0.04 Mil.
Medistim ASA's interest coverage for the quarter that ended in Mar. 2026 was 142.03.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Medistim ASA's Interest Coverage or its related term are showing as below:
STU:MD1'
s Interest Coverage Range Over the Past 10 Years
Min: 25.8 Med: 178.82 Max: 366.88
Current: 25.8
STU:MD1's Interest Coverage is ranked better than 59.44% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs STU:MD1: 25.80
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Medistim ASA Interest Coverage Related Terms
Medistim ASA Interest Coverage Historical Data
* Premium members only.
The historical data trend for Medistim ASA's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
STU:MD1 vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Medistim ASA's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistim ASA Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Medistim ASA's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medistim ASA (STU:MD1) has a Interest Coverage of 142.03 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medistim ASA and its competitors. This is 21% below median its historical median of 178.82. Over the past decade, Medistim ASA's Interest Coverage has ranged from 25.80 to 366.88. According to the industry distribution chart, Medistim ASA ranks #189 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 40.6%.
Is Medistim ASA's Interest Coverage too high?
Medistim ASA's current Interest Coverage of 142.03 is 21% below median its 10-year median of 178.82. Over the past 10 years, this metric has ranged from a low of 25.80 to a high of 366.88. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Medistim ASA's value of 142.03 is 794.7% above this industry median. Based on the distribution chart, Medistim ASA ranks #189 out of 466 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medistim ASA has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medistim ASA ranks #189 out of 466 companies for Interest Coverage. This puts Medistim ASA in the upper half of its industry. The industry median Interest Coverage is 15.88. Medistim ASA's value of 142.03 is 794.7% above this benchmark. Historically, Medistim ASA's own Interest Coverage has ranged from 25.80 to 366.88 over the past decade. While the company's 10-year median is 178.82 vs. the industry median of 15.88, Medistim ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistim ASA's current Interest Coverage of 142.03 is 794.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medistim ASA and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistim ASA's current Interest Coverage is 142.03, which is 21% below median its own 10-year median of 178.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Medistim ASA (STU:MD1) has a current Interest Coverage of 142.03. The stock's GF Value™ is €22.51, compared to a current price of €19.95 — trading 11.4% below its estimated fair value. The current Interest Coverage is 142.03, which is 21% below median its 10-year median of 178.82 and 794.7% above the Medical Devices & Instruments industry median of 15.88. Medistim ASA's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Medistim ASA (STU:MD1), the current Interest Coverage is 142.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medistim ASA (STU:MD1) Overvalued in 2026?
Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued.
The current stock price of €19.95 is trading 11.4% below its estimated GF Value™ of €22.51.
Key valuation signals for STU:MD1:
Interest Coverage: 142.03 (21% below median its 10-year median of 178.82)
GF Value™: €22.51 vs. price of €19.95 (11.4% below fair value)
Industry Position: 794.7% above the Medical Devices & Instruments median (#189 of 466)
No single metric tells the full story. See the STU:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
92GF Score
Get the complete analysis for STU:MD1
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:MD1 has been successfully added to your 
